1. Market Research
  2. > Pathology
24 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028 Summary Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration ...

  • Lymphoma
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • Australasia

Graft Versus Host Disease (GvHD): Forecast in Asia-Pacific Markets to 2028

  • $ 8995
  • July 2020
  • 111 pages

ACHIEVING APPROVAL FOR CGVHD WITHOUT SIGNIFICANT CLINICAL EVIDENCE IS PARTIALLY DUE TO ITS MOA AND THE SUBSTANTIAL CLINICAL STUDIES CONDUCTED OF IMBRUVICA IN OTHER HEMATOLOGICAL INDICATIONS, INCLUDING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL).

  • Lymphoma
  • Therapy
  • Transplantation
  • Australasia
  • Forecast

2024 World Hematology and Flow Cytometry Analyzers and Reagents Market: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 25000
  • July 2020
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • January 2019
  • 201 pages

ALTHOUGH CELLTRION' S TRUXIMA WAS SIMILARLY TREATED BY THE FDA, THE COMPANY COMPLIED WITH REQUESTS FOR ADDITIONAL DATA AND IN NOVEMBER 2018, CELLTRION' S TRUXIMA WAS APPROVED, BUT ONLY FOR THE TREATMENT OF B-CELL NON-HODGKIN AND FOLLICULAR LYMPHOMAS (CELLTRION, PRESS RELEASE, ## NOV

  • Biosimilar
  • Hospital
  • Lymphoma
  • Therapy
  • Australasia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

  • $ 1995
  • November 2019
  • 180 pages

It also discontinued GSK-## in Phase I stage of development for follicular lymphoma, diffuse large Bcell lymphoma, solid tumor, and refractory multiple myeloma.

  • Lymphoma
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • Australasia

World Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation

  • $ 35000
  • September 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

World Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis

  • $ 37500
  • June 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • World

2024 Australia Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

2024 New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

2024 Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market: A 17-Country Analysis

  • $ 9500
  • July 2020
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

Australia Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

Australia Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • Australia

New Zealand Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • Australasia
  • New Zealand

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 9500
  • September 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

Asia-Pacific Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: A 17-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 14700
  • June 2019
  • 365 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • APAC
  • Australasia

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 211 pages

The targeted subindications are mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

  • Leukemia
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Australasia

Heparanase - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 43 pages

Initially, it stimulates the DC, leading to the activation of natural killer (NK) cells that are capable of destroying lymphomas.

  • Lymphoma
  • Therapy
  • Australasia
  • Product Initiative
  • Progen Pharmaceuticals Limited

Australia In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

  • $ 5995
  • April 2020
  • 503 pages

ASSOCIATE PROFESSOR WIEGMANS SAID THE STUDY COULD HAVE IMPLICATIONS FOR SEVERAL OTHER CANCERS WHERE DOXORUBICIN WAS USED, SUCH AS BLADDER, STOMACH, LUNG, OVARIAN, AND THYROID CANCERS AND SOME TYPES OF LEUKAEMIA AND HODGKIN S LYMPHOMA.

  • Infectious Disease
  • Lymphoma
  • Australasia
  • Australia
  • Oceania

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 152 pages

IT WAS ALSO UNDER DEVELOPMENT FOR METASTATIC PANCREATIC CANCER, ADVANCED SOLID TUMOR MALIGNANCIES OR LYMPHOMA.

  • Chemotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Pharmaceutical
  • Australasia
View report >

Cancer Statistics

  • February 2020
  • 66 pages

Salivary gland Polycythaemia vera Oropharynx Other lymphomas Thymus Eye Nose, nasal cavities, middle ear and accessory sinuses Larynx Other endocrine glands Skin of anus (including perineum, perianal skin) Nasopharynx Malignancy of histiocytes and accessory lymphoid cells Unspecified sites

  • Cancer
  • Lymphoma
  • Pathology
  • Australasia
  • Demographic

Cancer Statistics June 2019

Gasoline Market October 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on